Cargando…

Editorial: Identification of therapeutic targets and novel biomarkers in prostate cancer volume II

Detalles Bibliográficos
Autores principales:	Sharad, Shashwat, Srinivasan, Alagarsamy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025561/ https://www.ncbi.nlm.nih.gov/pubmed/36950555 http://dx.doi.org/10.3389/fonc.2023.1163235

Ejemplares similares

PMEPA1 Gene Isoforms: A Potential Biomarker and Therapeutic Target in Prostate Cancer
por: Sharad, Shashwat, et al.
Publicado: (2020)

Editorial: Women in cancer molecular targets and therapeutics, volume II: 2022
por: Berindan-Neagoe, Ioana, et al.
Publicado: (2023)

Editorial: Biomarkers in genitourinary cancers: Volume II
por: Yuasa, Takeshi
Publicado: (2022)

Identification of the novel therapeutic targets and biomarkers associated of prostate cancer with cancer-associated fibroblasts (CAFs)
por: Zhai, Xinyu, et al.
Publicado: (2023)

Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer, Volume II
por: Zhong, Weilong, et al.
Publicado: (2023)

Editorial: Altered expression of proteins in cancer: function and potential therapeutic targets, volume II
por: Pessoa, João, et al.
Publicado: (2023)

Editorial: Novel diagnostic and therapeutic strategies in the management of cerebral gliomas, Volume II
por: Bosio, Alberto, et al.
Publicado: (2023)

Editorial: Therapeutic drug monitoring and clinical toxicology of anti-cancer drugs, volume II
por: Yan, Miao, et al.
Publicado: (2023)

Editorial: Identification of novel biomarkers for pancreatic and hepatocellular cancers
por: Matteucci, Laura, et al.
Publicado: (2022)

Editorial: Biomarkers in Genitourinary Cancers, Volume I
por: Videira, Paula Alexandra, et al.
Publicado: (2022)

Editorial: Women in gastrointestinal cancers, volume II: 2022
por: Hamdy, Nadia M., et al.
Publicado: (2023)

Characterization of unique PMEPA1 gene splice variants (isoforms d and e) from RNA Seq profiling provides novel insights into prognostic evaluation of prostate cancer
por: Sharad, Shashwat, et al.
Publicado: (2020)

Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets
por: Naik, Adviti, et al.
Publicado: (2022)

Editorial: Women in head and neck cancer, volume II: 2022
por: Economopoulou, Panagiota, et al.
Publicado: (2023)

Editorial: COVID-19 and hematological malignancies: Volume II
por: Wilde, Lindsay, et al.
Publicado: (2022)

Editorial: Heparan Sulfate Proteoglycans and Their Endogenous Modifying Enzymes: Cancer Players, Biomarkers and Therapeutic Targets
por: Lanzi, Cinzia, et al.
Publicado: (2020)

Transcription Factors as Novel Therapeutic Targets and Drivers of Prostate Cancer Progression
por: Xie, Kangzhe, et al.
Publicado: (2022)

Editorial: RNA and RNA modification in the pathogenesis, diagnosis and treatment of cancers, Volume II
por: Lu, Qisi, et al.
Publicado: (2023)

Editorial: Immune-related adverse events for patients with lung cancer-volume II
por: Wang, Yusha, et al.
Publicado: (2023)

Editorial: Antimycobacterial drug discovery: molecular therapeutics and target identification, Volume II
por: Gunosewoyo, Hendra, et al.
Publicado: (2023)

Editorial: Immunometabolism and therapeutic targeting of aggressive cancers
por: Ždralević, Maša, et al.
Publicado: (2023)

Editorial: Identifying novel biomarkers in bladder cancer
por: Ecke, Thorsten H., et al.
Publicado: (2023)

Editorial: Biomarkers, functional mechanisms, and therapeutic potentials in gastrointestinal cancers
por: Huang, Jun, et al.
Publicado: (2023)

Novel serum proteomic biomarkers for early diagnosis and aggressive grade identification of prostate cancer
por: Wang, Ce, et al.
Publicado: (2022)

Editorial: Women in molecular and cellular oncology, volume II: 2022
por: Dhar, Shilpa S.
Publicado: (2023)

Identification of Proteins Deregulated by Platinum-Based Chemotherapy as Novel Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer
por: Ryan, Sarah-Louise, et al.
Publicado: (2021)

Transcriptional Reprogramming and Novel Therapeutic Approaches for Targeting Prostate Cancer Stem Cells
por: Civenni, Gianluca, et al.
Publicado: (2019)

Identification of therapeutic targets and prognostic biomarkers in cholangiocarcinoma via WGCNA
por: Xu, Lei, et al.
Publicado: (2022)

Editorial: Molecular Targets and Therapeutic Strategies in Gynecological Cancers
por: Lu, Ziwen, et al.
Publicado: (2022)

Editorial: Novel circulating biomarkers and radiomics in pancreatic cancer
por: Ren, Shuai, et al.
Publicado: (2023)

Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets
por: He, Jiangnan, et al.
Publicado: (2021)

Identification of the γ-glutamyl cycle as a novel therapeutic target and 5-oxoproline as a new biomarker for diagnosing pancreatic cancer
por: Wang, Weijia, et al.
Publicado: (2023)

Editorial: Molecular advances in diagnosis and treatment of CNS tumors, volume II
por: Chen, Clark, et al.
Publicado: (2023)

Editorial: Ubiquitin-Modifying Enzymes as Drug Targets and Biomarkers in Cancer
por: Bell, Jessica L., et al.
Publicado: (2021)

Identification of Novel Molecular Therapeutic Targets and Their Potential Prognostic Biomarkers Based on Cytolytic Activity in Skin Cutaneous Melanoma
por: Zhang, Haoxue, et al.
Publicado: (2022)

Editorial: Metabolism As a Therapeutic Target
por: Columbano, Amedeo, et al.
Publicado: (2017)

Identification of a prognostic biomarker predicting biochemical recurrence and construction of a novel nomogram for prostate cancer
por: Yu, Zhaojun, et al.
Publicado: (2023)

Editorial: Therapeutic Opportunities and Innovative Biomarkers in Tumor Microenvironment
por: Xu, Kexin, et al.
Publicado: (2021)

Editorial: The Microenvironment in Pancreatic Cancer and Therapeutic Strategies Targeting Microenvironment
por: Duan, Wanxing, et al.
Publicado: (2022)

Editorial: Epigenetics in prostate cancer
por: Baniahmad, Aria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_phn0aknsmohdcik6htkqop0iai